ARCHIVES

Ronald DePinho Apologizes, Takes Responsibility For “Morale Issues” at MD Anderson

This article is from The Cancer Letter archive.

Vol. 39 No. 36 | September 27, 2013

Download PDF Visit The Full Archive

Related Articles

EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure.

March 2, 2007

Study: Drug Discounts Used For Wealthier Patients In Many 340B-Enrolled Hospitals

October 10, 2014

Workers Ignorant Of Benzidine Risk, Union tells Congress

April 3, 1987

Scientific Opportunity Should Guide Fund Allocation, House Says

August 4, 1995

Paulette Gray named director of NCI Division of Extramural Activities.

April 22, 2005

Flood Says Congress Will Renew Cancer Act, But Only After “All Out” Review of Research Policy

December 3, 1976